ProGenTech Partners With the China CDC to Develop an Automated Molecular Diagnostic Platform and Assays

EMERYVILLE, Calif., Dec 18, 2008 -- ProGenTech Limited, a life science and molecular diagnostics company based in Shanghai, China and the San Francisco Bay Area has signed a collaboration agreement with the China CDC to create a joint laboratory that will focus on developing next generation molecular diagnostic systems and assays. Under the terms of [...]

Fluxion Moves into Germany and Austria with New Distribution Agreement

IUL Instruments GmbH to Distribute BioFlux Line of Live Cell Imaging Products Fluxion Biosciences announced today an exclusive distribution agreement with IUL Instruments GmbH. IUL, based in Königswinter, Germany, will handle sales and service in Germany and Austria of Fluxion's BioFlux research tools for live cell image analysis in drug discovery. IUL Instruments GmbH, founded [...]

Researchers Successfully Used the 454 Sequencing System for Sensitive Detection of HIV Tropism

454 Life Sciences, a Roche company, announced today that a team of researchers from the BC Centre of Excellence in HIV/AIDS and the University of British Columbia, Canada have used the Genome Sequencer FLX system to monitor low frequency HIV variants from human samples in a recent study. The preliminarily results of the study were [...]

CombiMatrix Announces Positive Results From Expanded HerScan Study

Company Reaffirms Its Regulatory Stance in Offering HerScan as a Laboratory Developed Test (LDT) in Response to Genentech FDA Citizen Petition Filing MUKILTEO, Wash., Dec. 18, 2008 -- CombiMatrix Corporation (NasdaqGM:CBMX - News) today announced that expanded study results on the company's HerScan(tm) array comparative genomic hybridization (array CGH) test demonstrated 97% concordance with fluorescent [...]

Bioheart Partners With Life Technologies to Offer Myoblast Cell Products to the Research Market

SUNRISE, Fla., Dec 18, 2008 -- Bioheart, Inc. (Nasdaq:BHRT) and Life Technologies Corporation (Nasdaq:LIFE) have entered into a global distribution and OEM agreement to sell myoblast cell-based research products to life science researchers. Life Technologies will offer Bioheart's myoblast stem cell products to the research community so that they may accelerate the development of myoblast [...]

Highly Efficient & Flexible Parallel Research System…

The Synthesis 1 from Heidolph UK (www.heidolph-uk.co.uk) is a highly flexible system that can be configured for parallel solid and liquid phase synthesis as well as multiple evaporation experiments thereby increasing the efficiency of your chemistry. Interchangeable plug and play reaction blocks enable the Synthesis 1 to be quickly configurable to perform a wide range [...]

Bruker Daltonics Introduces Sensitive, Five Minute Melamine Food Safety Testing Solution Based on Robust and Cost-Effective HCT Ion Trap Mass Spectrometry

BILLERICA, Mass.--Bruker Daltonics today has released a robust, fast and highly sensitive high-capacity ion trap HCT™ solution for the detection and quantification of melamine and cyanuric acid (CA) by food safety laboratories. Since September 2008, thousands of infants and young children in China have been hospitalized to treat the symptoms caused by the ingestion of [...]

Olivier Filliol Joins METTLER TOLEDO Board of Directors

COLUMBUS, Ohio, Dec. 18 -- Mettler-Toledo International Inc. (NYSE: MTD - News) announced today that its Chief Executive Officer Olivier Filliol has been appointed to its Board of Directors, effective January 1, 2009. The Company also announced that Robert F. Spoerry will continue to serve as Chairman of the Board. Mr. Spoerry stated, "I am [...]

Invitrogen Launches Solutions to Simplify DNA and RNA Workflows on Next-Generation Sequencing Systems

Invitrogen, part of Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced the introduction of two reagent solutions to simplify genomic and transcriptome analysis on next-generation, high-throughput genomic analysis platforms. Both solutions provide basic and clinical researchers with an innovative workflow that greatly reduces the time, cost, and experimental variability [...]

Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis

Total acquisition price will be $215 million Acquisition will expand Abbott's position in molecular diagnostics for infectious disease CARLSBAD, Calif. and ABBOTT PARK, Ill., Dec. 17 -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Abbott (NYSE: ABT) announced today that Abbott has exercised its option to purchase the remaining equity ownership in Ibis Biosciences, Inc., an [...]

Access IBO on Knowledge Center